Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | CETP | P11597 | 3/20 | 0.47 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.44 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.43 |
| ▸ | MTOR | P42345 | 1/20 | 0.43 |
| ▸ | AGXT | P21549 | 1/20 | 0.43 |
| ▸ | ALPG | P10696 | 1/20 | 0.43 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.41 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.41 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL206609 | 0.81 | TSHR (0.68) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL3705675 | 0.79 | TSHR (0.65) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL3367144 | 0.78 | TSHR (0.64) | TSHRCETPSRCPDPK1MTOR | |
| SCHEMBL5032692 | 0.78 | TSHR (0.59) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL389180 | 0.77 | TSHR (0.63) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL8533600 | 0.77 | TSHR (0.63) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL12831300 | 0.77 | TSHR (0.63) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL79996 | 0.77 | TSHR (0.63) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL14263644 | 0.77 | TSHR (0.63) | TSHRCETPIDO1SRCPDPK1 | |
| SCHEMBL8361083 | 0.77 | TSHR (0.63) | TSHRCETPIDO1SRCPDPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4720050-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2026-04-08 | — | — | EP | claimed |
| EP-4074719-B1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC SYNTHETIC PHARMACEUTICAL CO LTD (CN) | 2025-12-03 | — | — | EP | claimed |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2024-12-24 | — | — | US | claimed |
| WO-2024249672-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2024-12-05 | — | — | WO | claimed |
| CN-117567455-A | Novel oxazolidinone compound and synthetic method and application thereof | 华创合成制药股份有限公司 | 2024-02-20 | — | — | CN | claimed |
| US-20230046407-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2023-02-16 | — | — | US | claimed |
| EP-4074719-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2022-10-19 | — | — | EP | claimed |
| EP-0998518-B1 | PROCESS FOR THE PREPARATION OF POLYETHER PHOSPHATES | AMERSHAM HEALTH AS (NO) | 2003-12-10 | — | — | EP | claimed |
| EP-4720050-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2026-04-08 | — | — | EP | disclosed |
| EP-4074719-B1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC SYNTHETIC PHARMACEUTICAL CO LTD (CN) | 2025-12-03 | — | — | EP | disclosed |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2024-12-24 | — | — | US | disclosed |
| WO-2024249672-A1 | PROCESS OF PREPARING HIV CAPSID INHIBITOR | GILEAD SCIENCES, INC. (US) | 2024-12-05 | — | — | WO | disclosed |
| CN-117567455-A | Novel oxazolidinone compound and synthetic method and application thereof | 华创合成制药股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| US-20230046407-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2023-02-16 | — | — | US | disclosed |
| EP-4074719-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | HC Synthetic Pharmaceutical Co., Ltd. (CN) | 2022-10-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230046407-A1 | NEW-TYPE OXAZOLIDINONE COMPOUNDS AND PREPARATION METHOD THEREFOR | CYP4F11, OXA1L, WEE2 | TSHR 3107/4885CETP 2341/4885IDO1 4429/4885 |
| US-12173020-B2 | New-type oxazolidinone compounds and preparation method therefor | CYP4F11, OXA1L, WEE2 | TSHR 3107/4885CETP 2341/4885IDO1 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.